Phase II Trial of Loubo^®(Lobaplatin) and Pemetrexed for Patients with Metastatic Breast Cancer not Responding to Anthracycline or Taxanes

Anti-Proliferation Effects and Molecular Mechanisms of Action of Tetramethypyrazine on Human SGC-7901 Gastric Carcinoma Cells

“…Data are presented as means ± standard deviation (SD). We have enough experience in conducting medical researches, and have published some results elsewhere Dai et al, 2013;Deng et al, 2013;Gu et al, 2013;Fei et al, 2013;Shen et al, 2013;Sun et al, 2013;Wei et al, 2013;Yan et al, 2013;Gong et al, 2014;Zhang et al, 2014).…”

Lobaplatin Combined Floxuridine/Pirarubicin-based Transcatheter Hepatic Arterial Chemoembolization for Unresectable Primary Hepatocellular Carcinoma

“…In this way, LBP has shown good antitumour activity. In vivo, LBP remains good stability and low toxicity, some tumors resistanted to cisplatin are still sensitive to LBP.LBP has activity in a wider range of tumour types (McKeage, 2001;Wu, et al, 2010;Deng et al, 2013;Huang et al, 2013). LBP has been approved good inhibitory effect for the hepatocellular carcinoma cell lines (SMMC-27721, HepG2 and Bel2-7402) in the experiments in vitro (Qian et al, 2009).…”

Application of Lobaplatin in Trans-catheter Arterial Chemoembolization for Primary Hepatic Carcinoma

“…Characterized by good water solubility, broad anti-tumor spectrum, strong anti-tumor activity, no achiasmate drug resistance with other platinum-based drugs and low toxicity, it exerts definite effects in the treatment of various tumors, such as breast cancer (Engel et al, 2012;Deng et al, 2013), lung cancer (Xie et al, 2012), esophageal carcinoma, gastrointestinal cancer and malignant pleural effusion and ascites. In terms of primary hepatic carcinoma, the in-vitro experimental studies have demonstrated that LBP has an inhibitory effect on hepatocellular carcinoma cells, and can be recommended to treat primary hepatic carcinoma in clinic (Qian et al, 2009;Wu et al, 2010;Wang et al, 2012).…”